Endiya Partners has invested in Eyestem, a Bengaluru-based company developing affordable Cell Therapy Solutions. It is currently in the pre human-trial stage for a cell therapy led treatment for Dry Age-related Macular Degeneration.

1. Private & Confidential Copyrighted 2019 1
Eyestem – Why did we invest?
The Investor’s Cut

2. About Endiya
Endiya Partners is an early-stage venture capital fund that invests in IP-led Indian
product start-ups that are globally relevant. Leveraging deep domain expertise
along with vast entrepreneurial and operating experience, the Endiya team plays
a key role in co-creating scalable businesses. Endiya’s portfolio consists of
disruptive and category-defining companies across Digital Transformation and
Healthcare sectors. Founded in 2015, Endiya Partners has $100M under
management.
Team : Sateesh Andra , Dr. Ramesh Byrapaneni, Abhishek Shrivastava, Abhiram Katta

3. About Eyestem
Eyestem is a cell therapy company founded by a top-class management team
consisting of clinical trials, cell therapy, and ophthalmology experts. It also boasts
a world-class advisory board and has built collaborations with pioneers and
leaders in the space. Its lead candidate-Eyecyte-RPE for age-related macular
degeneration will enter human trials shortly. Its long-term vision is to
democratize access to cell therapy by creating a create scalable cell therapy
platform to treat incurable diseases.
Founders : Dr. Jogin Desai , Dr. Rajani Battu, Dr. Dhruv Sareen, Dr. Rajarshi Pal

4. Eyestem Investment Decision
Interest in Cell
Therapy
Highly Qualified
Team
Focus on
Affordability
•No Clear Winner yet globally
•Eyestem’s mission to build affordable solutions
•Targeting Age related Macular degeneration – An Area
with high chance of success
•Eyestem’s Eyecyte –RPE has excellent efficacy results –
shortly in Human Trials
•Depth of Medical Knowledge
•Understanding of Clinical Trials
•Ophthalmologists and Scientists in Team
•Management experience
•World renowned experts in Advisory Board
•Democratizing Cell Therapy
•Access to Larger Markets
•Business with a mission that benefits humanity

5. Eyestem : Journey Ahead
“Over my interactions with the Eyestem team, as I gathered more information about their ambition, their
deep research, and business principles, I was convinced about Endiya’s interest in backing their journey. At
Endiya we have always been a launch-pad for companies in Technology and Healthcare, which challenge
the normal and offer solutions to problems of consumers and humankind at large. Eyestem has been
doing that with grit and passion and I am sure that they would succeed in the novel mission they have
undertaken.”
- Dr. Ramesh Byrapaneni